Contracting and Reimbursement
- Simplify pricing and coding
- Effectively manage and share formulary changes
- Evaluate specialty pharmacy performance
- Validate formulary and medical benefit contracts
About MMIT
Who Is MMIT?
Over the last decade, MMIT has established itself as a trusted go-to-market partner—a compass for pharma companies hoping to navigate the path to better patient access.
Year after year, hundreds of manufacturers and life sciences organizations trust our blend of industry-standard data and insights to create an actionable understanding of the market access landscape. Our solutions deliver near-real-time data and insights that empower strategic decision-making and commercial execution.
What’s more, our clients can leverage the power of our parent company, Norstella, to combine MMIT’s coverage data solutions with Norstella’s real-world-data custom solutions. Our unique, connected data asset, NorstellaLinQ, provides access to critical patient data such as open and closed claims, lab data and electronic medical records.
Together, we have the data, insights and technology to help you understand market access and overcome commercial challenges within an increasingly complex industry.
Where We Came From
Since we first launched our company (then known as Medi-Media) more than two decades ago, we’ve been 100% focused on supporting pharmaceutical clients in key areas of commercialization. Since then, we’ve acquired several key companies to help us achieve our mission: Atlantic Information Services, the creator of the Directory of Health Plans and leading healthcare journalism publications; Zitter Health Insights, a provider of market access insights and solutions for specialty drugs; and RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit.
Where We’re Headed
MMIT is united with other market-leading pharmaceutical solutions providers—Citeline, Evaluate, Panalgo and The Dedham Group—under our parent company, Norstella.
Together, we fuel industry innovation, helping our clients connect the dots from pipeline to patient at every step of the drug development life cycle.
When MMIT clients choose NorstellaLinQ, they gain access to must-have answers for critical strategic and commercial decision-making along the entire drug development journey.
